ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

Centers Can Collaborate Well with Industry, Albert LoBuglio Says

May 7, 1999

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

Fisher, Redmond Removed Fro Official posts At NSABP

May 13, 1994

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011